Members

Managers

Yasunari Kanda Director, Division of Pharmacology, National Institute of Health Sciences
Kohei Sawada Global Cardiovascular Assessment, Biopharmaceutical Assessments Core Function Unit, Eisai Product Creation Systems / Board of Director of JSPS
Norimasa Miyamoto Global Cardiovascular Assessment, Biopharmaceutical Assessments Core Function Unit, Eisai Product Creation Systems / CSAHi

Participant Researchers or their Organizations

Kaoru Sato National Institute of Health Sciences
Seiichi Ishida National Institute of Health Sciences
Daiju Yamazaki National Institute of Health Sciences
Yuko Sekino Graduate School of Pharmaceutical Sciences, The University of Tokyo
Yoshinori Ide Pharmacological Evaluation Institute of Japan (PEIJ)
Atsushi Sugiyama School of Medical, Toho University
Atsuhiko Naito School of Medical, Toho University
Jun K. Yamashita Center for iPS Cell Research and Application, Kyoto University
Yoshinori Yoshida Center for iPS Cell Research and Application, Kyoto University
Junko Kurokawa School of Pharmaceutical Sciences, University of Shizuoka
Takashi Ashihara Shiga University of Medical Science
Mahito Nakanishi Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology
Japanese Safety Pharmacology Society (JSPS)
Eisai Product Creation Systems
Ono Pharmaceutical Co., Ltd.
Nippon Shinyaku Co., Ltd.
TEIJIN PHARMA LIMITED.
Shin Nippon Biomedical Laboratories, Ltd.
Alpha MED Scientific Inc.
Biotherapy Institute of Japan
Pharmacological Evaluation Institute of Japan (PEIJ)
  • Ministry of Health, Labour and Welfare
  • National Institute of Health Sciences
Page Top